Found: 21
Select item for more details and to access through your institution.
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology, 2006, v. 41, n. 5, p. 462, doi. 10.1007/s00535-006-1790-5
- By:
- Publication type:
- Article
Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 11, p. 6247, doi. 10.1002/jmv.27157
- By:
- Publication type:
- Article
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34962-7
- By:
- Publication type:
- Article
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1073, doi. 10.1007/s10147-023-02354-6
- By:
- Publication type:
- Article
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 941, doi. 10.1007/s10147-021-01859-2
- By:
- Publication type:
- Article
Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis.
- Published in:
- Hepatology Research, 2017, v. 47, n. 3, p. E193, doi. 10.1111/hepr.12748
- By:
- Publication type:
- Article
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment.
- Published in:
- Hepatology Research, 2016, v. 46, n. 2, p. 201, doi. 10.1111/hepr.12562
- By:
- Publication type:
- Article
Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients ( LEAN- J).
- Published in:
- Hepatology Research, 2015, v. 45, n. 3, p. 269, doi. 10.1111/hepr.12351
- By:
- Publication type:
- Article
A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
- Published in:
- Pathology International, 2013, v. 63, n. 8, p. 419, doi. 10.1111/pin.12081
- By:
- Publication type:
- Article
Retracted: Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.
- Published in:
- Medical Science Monitor, 2018, v. 24, p. 1768, doi. 10.12659/MSM.909667
- By:
- Publication type:
- Article
Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.
- Published in:
- Medical Science Monitor, 2017, v. 23, p. 4028, doi. 10.12659/MSM.902576
- By:
- Publication type:
- Article
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165339
- By:
- Publication type:
- Article
The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey.
- Published in:
- Journal of Gastroenterology, 2015, v. 50, n. 3, p. 333, doi. 10.1007/s00535-014-0968-5
- By:
- Publication type:
- Article
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
- Published in:
- Oncology, 2023, v. 101, n. 1, p. 22, doi. 10.1159/000527176
- By:
- Publication type:
- Article
Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.
- Published in:
- JGH Open, 2017, v. 1, n. 4, p. 148, doi. 10.1002/jgh3.12026
- By:
- Publication type:
- Article
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46924-0
- By:
- Publication type:
- Article
Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.
- Published in:
- Journal of Gastroenterology & Hepatology, 2008, v. 23, n. 6, p. 908, doi. 10.1111/j.1440-1746.2008.05366.x
- By:
- Publication type:
- Article
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194704
- By:
- Publication type:
- Article